The anti-CSPG4 IgG1 constructs demonstrated the ability to mediate substantially effective antibody-dependent cellular phagocytosis (ADCP) in patient-derived monocytes and reduced tumour size in human melanoma xenograft models. The gene discussed is CSPG4; the disease is melanoma.